{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:28:26Z","timestamp":1789644506329,"version":"4.0.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To define the impact of perineural invasion (PNI) on long-term survival of patients following curative-intent resection of pancreatic neuroendocrine tumors (pNETs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>Patients with pNETs who underwent curative-intent resection (R0\/R1) between 2000 and 2020 were identified from a multi-institutional database. The impacts of PNI on overall survival (OS) and disease-free survival (DFS) were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 700 patients, 171 (\n                      <jats:italic>n<\/jats:italic>\n                      = 24.4%) had a pNET with PNI. The presence of PNI was associated with higher tumor grade (G3, 8.2% vs. 2.5%,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001), more advanced AJCC T disease (T3\u2013T4, 58.5% vs. 15.9%,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001), and a higher incidence of nodal metastasis (52.6% vs. 21.2%,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001) versus patients with no PNI. Patients with PNI had a worse OS (median, with PNI 115.9\u00a0months vs. no PNI not reached,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001) and DFS (median, with PNI 51.9 vs. no PNI 115.4\u00a0months,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001) versus patients with no PNI. On multivariable analysis PNI was an independent risk factor associated with worse OS (HR = 2.624, 95%CI 1.475\u20134.668,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.001), as well as DFS (HR = 1.972, 95%CI 1.396\u20132.786,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001). Among 256 patients with very early staged tumors (G1N0) who underwent an R0 resection, PNI remained a strong independent factor associated with worse long-term survivals (OS, HR = 3.892, 95%CI 1.196\u201312.662,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.024; DFS, HR = 2.530, 95%CI 1.010\u20136.339,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.048).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PNI was an independent adverse prognostic factor among patients undergoing curative-intent resection of pNETs, even among individuals with early-stage disease. The presence of PNI should be routinely assessed and considered in the prognostic stratification of patients following resection of pNETs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-025-18561-6","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T16:42:13Z","timestamp":1760632933000},"page":"1586-1594","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Perineural Invasion Worsens Long-Term Outcomes of Pancreatic Neuroendocrine Tumors Following Surgical Resection"],"prefix":"10.1245","volume":"33","author":[{"given":"Hui","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Jing","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Xi","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra G.","family":"Lopez-Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Poultsides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Fields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Idrees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cliff","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shishir K.","family":"Maithel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7994-9870","authenticated-orcid":false,"given":"Timothy M.","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"18561_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.critrevonc.2016.03.013","volume":"101","author":"A Vi\u00fadez","year":"2016","unstructured":"Vi\u00fadez A, De Jesus-Acosta A, Carvalho FL, Vera R, Mart\u00edn-Algarra S, Ram\u00edrez N. Pancreatic neuroendocrine tumors: challenges in an underestimated disease. Crit Rev Oncol Hematol. 2016;101:193\u2013206.","journal-title":"Crit Rev Oncol Hematol."},{"key":"18561_CR2","doi-asserted-by":"publisher","first-page":"188804","DOI":"10.1016\/j.bbcan.2022.188804","volume":"1877","author":"J Pozas","year":"2022","unstructured":"Pozas J, Alonso-Gordoa T, Roman MS, et al. Novel therapeutic approaches in GEP-NETs based on genetic and epigenetic alterations. Biochim Biophys Acta Rev Cancer. 2022;1877:188804.","journal-title":"Biochim Biophys Acta Rev Cancer."},{"key":"18561_CR3","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1245\/s10434-020-08620-5","volume":"27","author":"JX Xiang","year":"2020","unstructured":"Xiang JX, Zhang XF, Weiss M, et al. Multi-institutional development and external validation of a nomogram predicting recurrence after curative liver resection for neuroendocrine liver metastasis. Ann Surg Oncol. 2020;27:3717\u201326.","journal-title":"Ann Surg Oncol."},{"key":"18561_CR4","doi-asserted-by":"publisher","first-page":"e773","DOI":"10.1097\/SLA.0000000000004039","volume":"275","author":"XF Zhang","year":"2022","unstructured":"Zhang XF, Xue F, Wu Z, et al. Development and validation of a modified eighth AJCC staging system for primary pancreatic neuroendocrine tumors. Ann Surg. 2022;275:e773\u201380.","journal-title":"Ann Surg."},{"key":"18561_CR5","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1097\/MPA.0b013e31823cdaa0","volume":"41","author":"JR Parekh","year":"2012","unstructured":"Parekh JR, Wang SC, Bergsland EK, et al. Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients. Pancreas. 2012;41:840\u20134.","journal-title":"Pancreas."},{"key":"18561_CR6","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1093\/annonc\/mdi358","volume":"16","author":"P Tomassetti","year":"2005","unstructured":"Tomassetti P, Campana D, Piscitelli L, et al. Endocrine pancreatic tumors: factors correlated with survival. Ann Oncol. 2005;16:1806\u201310.","journal-title":"Ann Oncol."},{"key":"18561_CR7","first-page":"471","volume":"68","author":"M Cives","year":"2018","unstructured":"Cives M, Strosberg JR. Gastroenteropancreatic neuroendocrine tumors. CA Cancer J Clin. 2018;68:471\u201387.","journal-title":"CA Cancer J Clin."},{"key":"18561_CR8","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3:1335\u201342.","journal-title":"JAMA Oncol."},{"key":"18561_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrc.2016.38","volume":"16","author":"M Amit","year":"2016","unstructured":"Amit M, Na\u2019ara S, Gil Z. Mechanisms of cancer dissemination along nerves. Nat Rev Cancer. 2016;16:399\u2013408.","journal-title":"Nat Rev Cancer."},{"key":"18561_CR10","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1158\/2159-8290.CD-18-1398","volume":"9","author":"S Faulkner","year":"2019","unstructured":"Faulkner S, Jobling P, March B, Jiang CC, Hondermarck H. Tumor neurobiology and the war of nerves in cancer. Cancer Discov. 2019;9:702\u201310.","journal-title":"Cancer Discov."},{"key":"18561_CR11","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/bjs\/znac098","volume":"109","author":"T Wei","year":"2022","unstructured":"Wei T, Zhang XF, He J, et al. Prognostic impact of perineural invasion in intrahepatic cholangiocarcinoma: multicentre study. Br J Surg. 2022;109:610\u20136.","journal-title":"Br J Surg."},{"key":"18561_CR12","doi-asserted-by":"crossref","unstructured":"Schouten TJ, Kroon VJ, Besselink MG, et al. Perineural invasion is an important prognostic factor in patients with radically resected (R0) and node-negative (pN0) pancreatic cancer. Ann Surg. 2024.","DOI":"10.1097\/SLA.0000000000006320"},{"key":"18561_CR13","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1186\/s12885-023-11196-4","volume":"23","author":"K Li","year":"2023","unstructured":"Li K, Zhao F, Guo Y, et al. Interaction analysis of high-risk pathological features on adjuvant chemotherapy survival benefit in stage II colon cancer patients: a multi-center, retrospective study. BMC Cancer. 2023;23:797.","journal-title":"BMC Cancer."},{"key":"18561_CR14","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/s41388-020-01615-2","volume":"40","author":"L Yin","year":"2021","unstructured":"Yin L, Li J, Wang J, et al. MAOA promotes prostate cancer cell perineural invasion through SEMA3C\/PlexinA2\/NRP1-cMET signaling. Oncogene. 2021;40:1362\u201374.","journal-title":"Oncogene."},{"key":"18561_CR15","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1002\/cncr.24396","volume":"115","author":"C Liebig","year":"2009","unstructured":"Liebig C, Ayala G, Wilks JA, Berger DH, Albo D. Perineural invasion in cancer: a review of the literature. Cancer. 2009;115:3379\u201391.","journal-title":"Cancer."},{"key":"18561_CR16","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41388-020-01578-4","volume":"40","author":"X Tan","year":"2021","unstructured":"Tan X, Sivakumar S, Bednarsch J, et al. Nerve fibers in the tumor microenvironment in neurotropic cancer-pancreatic cancer and cholangiocarcinoma. Oncogene. 2021;40:899\u2013908.","journal-title":"Oncogene."},{"key":"18561_CR17","doi-asserted-by":"publisher","first-page":"630316","DOI":"10.3389\/fonc.2021.630316","volume":"11","author":"H Zhou","year":"2021","unstructured":"Zhou H, Wang Y, Guo C, et al. Microscopic invasion of nerve is associated with aggressive behaviors in pancreatic neuroendocrine tumors. Front Oncol. 2021;11:630316.","journal-title":"Front Oncol."},{"key":"18561_CR18","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/jso.25716","volume":"120","author":"DH Dong","year":"2019","unstructured":"Dong DH, Zhang XF, Poultsides G, et al. Impact of tumor size and nodal status on recurrence of nonfunctional pancreatic neuroendocrine tumors \u22642 cm after curative resection: a multi-institutional study of 392 cases. J Surg Oncol. 2019;120:1071\u20139.","journal-title":"J Surg Oncol."},{"key":"18561_CR19","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1016\/j.asjsur.2022.01.094","volume":"45","author":"BS Shyr","year":"2022","unstructured":"Shyr BS, Shyr BU, Chen SC, Shyr YM, Wang SE. Impact of tumor grade on pancreatic neuroendocrine tumors. Asian J Surg. 2022;45:2659\u201363.","journal-title":"Asian J Surg."},{"key":"18561_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12957-025-03734-0","volume":"23","author":"W Izumo","year":"2025","unstructured":"Izumo W, Kawaida H, Saito R, et al. Evaluation of the details and importance of lymphatic, microvascular, and perineural invasion in patients with non-functioning pancreatic neuroendocrine neoplasms based on tumor size and the 2022 World Health Organization classification: a 23\u00a0year retrospective analysis. World J Surg Oncol. 2025;23:79.","journal-title":"World J Surg Oncol."},{"key":"18561_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.suronc.2017.01.007","volume":"26","author":"S Schorn","year":"2017","unstructured":"Schorn S, Demir IE, Haller B, et al. The influence of neural invasion on survival and tumor recurrence in pancreatic ductal adenocarcinoma\u2014A systematic review and meta-analysis. Surg Oncol. 2017;26:105\u201315.","journal-title":"Surg Oncol."},{"key":"18561_CR22","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12885-021-08045-7","volume":"21","author":"R Imam","year":"2021","unstructured":"Imam R, Chang Q, Black M, Yu C, Cao W. CD47 expression and CD163(+) macrophages correlated with prognosis of pancreatic neuroendocrine tumor. BMC Cancer. 2021;21:320.","journal-title":"BMC Cancer."},{"key":"18561_CR23","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000534075","volume":"114","author":"J-X Xiang","year":"2024","unstructured":"Xiang J-X, Qian Y-R, He J, et al. Low prognostic nutritional index is common and associated with poor outcomes following curative-intent resection for gastro-entero-pancreatic neuroendocrine tumors. Neuroendocrinology. 2024;114:158\u201369.","journal-title":"Neuroendocrinology."},{"key":"18561_CR24","doi-asserted-by":"publisher","first-page":"839","DOI":"10.6004\/jnccn.2021.0032","volume":"19","author":"MH Shah","year":"2021","unstructured":"Shah MH, Goldner WS, Benson AB, et al. Neuroendocrine and adrenal tumors, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19:839\u201368.","journal-title":"J Natl Compr Canc Netw."},{"key":"18561_CR25","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1097\/CM9.0000000000002848","volume":"136","author":"F Jiao","year":"2023","unstructured":"Jiao F, Cui J, Fu D, et al. Chinese medical association consensus for standardized diagnosis and treatment of pancreatic neuroendocrine neoplasms. Chin Med J (Engl). 2023;136:2397\u2013411.","journal-title":"Chin Med J (Engl)."},{"key":"18561_CR26","doi-asserted-by":"publisher","first-page":"13628","DOI":"10.1038\/s41598-023-40833-y","volume":"13","author":"S Borsekofsky","year":"2023","unstructured":"Borsekofsky S, Tsuriel S, Hagege RR, Hershkovitz D. Perineural invasion detection in pancreatic ductal adenocarcinoma using artificial intelligence. Sci Rep. 2023;13:13628.","journal-title":"Sci Rep."},{"key":"18561_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13244-024-01664-1","volume":"15","author":"NJ Liu","year":"2024","unstructured":"Liu NJ, Liu MS, Tian W, et al. The value of machine learning based on CT radiomics in the preoperative identification of peripheral nerve invasion in colorectal cancer: a two-center study. Insights Imaging. 2024;15:101.","journal-title":"Insights Imaging."},{"key":"18561_CR28","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1186\/s12885-025-14759-9","volume":"25","author":"S Deng","year":"2025","unstructured":"Deng S, Huang D, Han X, et al. A novel MRI-based habitat analysis and deep learning for predicting perineural invasion in prostate cancer: a two-center study. BMC Cancer. 2025;25:1367.","journal-title":"BMC Cancer."},{"key":"18561_CR29","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1007\/s10278-024-01325-1","volume":"38","author":"W Lu","year":"2025","unstructured":"Lu W, Zhong Y, Yang X, et al. Preoperative prediction of perineural invasion in pancreatic ductal adenocarcinoma using machine learning radiomics based on contrast-enhanced CT imaging. J Imaging Inform Med. 2025;38:1976\u201385.","journal-title":"J Imaging Inform Med."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18561-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18561-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18561-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T13:11:45Z","timestamp":1767618705000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18561-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["18561"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18561-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"assertion":[{"value":"27 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}